Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
$0.30
-2.7%
$0.35
$0.14
$0.80
$36.39M0.693,193 shs5,433 shs
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.22
-4.7%
$1.32
$0.88
$1.71
$136.42M0.77548,835 shs335,446 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.81
-4.1%
$0.64
$0.38
$3.03
$127.90M2.114.20 million shs1.57 million shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$4.33
-1.4%
$4.32
$3.22
$7.12
$133.28M1.9235,111 shs162,462 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
0.00%+2.00%-16.28%-32.92%-19.63%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
0.00%-2.29%-6.57%+25.49%0.00%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-2.12%-8.59%+28.14%+79.20%-55.74%
Avita Medical Inc. stock logo
RCEL
Avita Medical
+4.52%-2.01%+1.39%-12.72%-29.31%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
$0.30
-2.7%
$0.35
$0.14
$0.80
$36.39M0.693,193 shs5,433 shs
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.22
-4.7%
$1.32
$0.88
$1.71
$136.42M0.77548,835 shs335,446 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.81
-4.1%
$0.64
$0.38
$3.03
$127.90M2.114.20 million shs1.57 million shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$4.33
-1.4%
$4.32
$3.22
$7.12
$133.28M1.9235,111 shs162,462 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
0.00%+2.00%-16.28%-32.92%-19.63%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
0.00%-2.29%-6.57%+25.49%0.00%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-2.12%-8.59%+28.14%+79.20%-55.74%
Avita Medical Inc. stock logo
RCEL
Avita Medical
+4.52%-2.01%+1.39%-12.72%-29.31%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
0.00
N/AN/AN/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2.33
Hold$8.50593.88% Upside
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
2.40
Hold$5.40566.67% Upside
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.33
Hold$7.2568.41% Upside

Current Analyst Ratings Breakdown

Latest BNXTF, CRDL, GUTS, and RCEL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
UpgradeHoldBuy$3.50 ➝ $6.00
5/12/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Reiterated RatingSell (E+)
4/24/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Reiterated RatingBuy$8.00
4/8/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
Reiterated RatingBuy$10.00
4/6/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Reiterated RatingBuy$8.00
3/27/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
Reiterated RatingSell (E+)
3/26/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Reiterated RatingBuy$8.00
3/5/2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
Initiated CoverageOutperform$10.00
(Data available from 5/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
$20K1,819.53N/AN/A($0.05) per share-5.94
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/A$0.16 per shareN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$90K1,427.85N/AN/A$0.13 per share6.23
Avita Medical Inc. stock logo
RCEL
Avita Medical
$71.61M1.85N/AN/A($0.75) per share-5.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
-$5.43M-$0.04N/AN/AN/AN/AN/A-724.88%N/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$24.20M-$0.28N/AN/AN/AN/A-229.43%-165.60%8/13/2026 (Estimated)
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$140.95M-$1.29N/AN/AN/AN/A-4,053.15%-96.41%8/11/2026 (Estimated)
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$48.59M-$1.57N/AN/AN/A-62.67%N/A-78.92%8/6/2026 (Estimated)

Latest BNXTF, CRDL, GUTS, and RCEL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/29/2026Q1 2026
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
N/A-$0.01N/A-$0.02N/AN/A
5/14/2026Q1 2026
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million
5/12/2026Q1 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.17$0.06+$0.23$0.06N/AN/A
5/11/2026Q1 2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.07-$0.07N/A-$0.07N/AN/A
4/29/2026Q4 2025
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
N/A-$0.01N/A-$0.01N/AN/A
3/30/2026Q4 2025
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.09-$0.05+$0.04-$0.05N/AN/A
3/24/2026Q4 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.19$0.15+$0.34-$0.07N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
N/AN/AN/AN/AN/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
N/A
0.22
0.22
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A
4.39
4.39
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
1.41
4.28
4.28
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/A
0.47
0.38

Institutional Ownership

CompanyInstitutional Ownership
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
N/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
27.66%

Insider Ownership

CompanyInsider Ownership
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
N/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8.52%
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioNxt Solutions Inc. stock logo
BNXTF
BioNxt Solutions
20122.49 millionN/ANot Optionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
20111.82 million105.95 millionNot Optionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
102158.65 million145.13 millionN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
13030.78 million29.92 millionOptionable

Recent News About These Companies

AVITA Medical to Host Investor Webinar Briefing
BTIG Reaffirms Their Hold Rating on Avita Medical (RCEL)
Avita (RCEL) Q1 2026 Earnings Call Transcript
Avita Medical Q1 Earnings Call Highlights
AVITA Medical Names Cary Vance as Chief Executive Officer
AVITA Medical, Inc. Investigated by the Portnoy Law Firm

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioNxt Solutions stock logo

BioNxt Solutions OTCMKTS:BNXTF

$0.30 -0.01 (-2.72%)
As of 12:58 PM Eastern

BioNxt Solutions Inc. engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains. In addition, the company offers psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. Further, it provides analytical testing and consulting services. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Cardiol Therapeutics stock logo

Cardiol Therapeutics NASDAQ:CRDL

$1.22 -0.06 (-4.69%)
Closing price 04:00 PM Eastern
Extended Trading
$1.25 +0.03 (+2.05%)
As of 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$0.81 -0.03 (-4.14%)
Closing price 04:00 PM Eastern
Extended Trading
$0.81 +0.01 (+0.72%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Avita Medical stock logo

Avita Medical NASDAQ:RCEL

$4.33 -0.06 (-1.37%)
Closing price 04:00 PM Eastern
Extended Trading
$4.29 -0.04 (-1.02%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.